Elevated insulin-like growth factor 2 mRNA binding protein 1 levels predict a poor prognosis in patients with breast carcinoma using an integrated multi-omics data analysis.

MLA

Shiqi Li, and Meixiu Jiang. “Elevated Insulin-like Growth Factor 2 MRNA Binding Protein 1 Levels Predict a Poor Prognosis in Patients with Breast Carcinoma Using an Integrated Multi-Omics Data Analysis.” Frontiers in Genetics, vol. 13, Aug. 2022, pp. 1–12. EBSCOhost, https://doi.org/10.3389/fgene.2022.994003.

APA

Shiqi Li, & Meixiu Jiang. (2022). Elevated insulin-like growth factor 2 mRNA binding protein 1 levels predict a poor prognosis in patients with breast carcinoma using an integrated multi-omics data analysis. Frontiers in Genetics, 13, 1–12. https://doi.org/10.3389/fgene.2022.994003

Chicago

Shiqi Li, and Meixiu Jiang. 2022. “Elevated Insulin-like Growth Factor 2 MRNA Binding Protein 1 Levels Predict a Poor Prognosis in Patients with Breast Carcinoma Using an Integrated Multi-Omics Data Analysis.” Frontiers in Genetics 13 (August): 1–12. doi:10.3389/fgene.2022.994003.